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Reconstructed human skin equivalents are currently being
investigated as in vitro models for the prediction of human
skin toxicity and irritation responses. Three different industrial
reconstructed skin models (EpiDerm, Episkin and SkinEthic)
and one in-house equivalent were characterized and compared
using light microscopy, immunohistochemistry and reduction of
(3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyl tetrazolium bromide)
(MTT). Their inter- and intra-batch variation was evaluated.
Histological examination showed a completely stratified
epithelium in all skin models, which closely resembled normal
human epidermis. Low intra-batch variation in tissue architec-
ture was observed in all skin models, but moderate to
considerable inter-batch variation was noticed. Evaluation of
the expression and localization of a number of differentiation-
specific protein markers revealed that all skin models showed an
aberrant expression of keratin 6, skin-derived antileukoprotein-
ase, small proline rich proteins, involucrin and transglutamin-
ase. Although variation within batches was low, in particular
keratin 6, involucrin and skin-derived antileukoproteinase
expression demonstrated some inter-batch variation. Reduction
of MTT in vehicle-treated cultures showed high similarities
between skin models, but marked differences were observed
when 1.0% sodium lauryl sulfate was applied topically for 3 or
16 h. Most pronounced effects were noticed in SkinEthic
cultures. Intra-batch variations were low and moderate varia-
tions were observed between batches. All skin models tested
reproduced many of the characteristics of normal human
epidermis and therefore provide a morphologically relevant in
vitro means to assess skin irritation and other skin-related
studies. Key words: human skin equivalents; keratins; cornified
envelope precursors; MTT assay.
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Product safety testing and risk/benefit evaluation are con-
ducted in order to identify substances which may induce
adverse skin reactions and to assess human environmental
risks. Although during recent years numerous in vitro, non-
animal systems have been developed, no international
agreement exists for in vitro methods as alternatives to
animal studies (1, 2). Nevertheless, a promising contribution
may be provided by the reconstruction of human skin
equivalents in vitro.
Nowadays, various types of reconstructed human skin
exist. They are generated by growing differentiated keratino-
cyte cultures on acellular or fibroblast-populated dermal
substrates (3 – 9). These skin equivalents form a multilayered
epithelium composed of an organized stratum basale, stratum
spinosum, stratum granulosum and a stratum corneum.
Furthermore, they display characteristic epidermal ultrastruc-
tures (8, 10, 11) and they express markers of epidermal
differentiation (6, 12, 13). However, differences between
native and reconstructed epidermis are still evident.
Although extensive studies have been performed on the
application of skin models as tools for measurement of skin
irritation (14 – 18), no standard guidelines exist with regard to
quality control of the models, relevant biological endpoints
for assessing skin irritation and their predictive potential for
the in vivo situation. Moreover, for all applications it is
important to know that the results obtained from a skin
model are reproducible, both within a given batch and
between batches.
The aim of this study was to compare 3 different industrial
reconstructed skin models and one in-house equivalent on the
basis of light microscopic and immunohistochemical exam-
ination, and to evaluate their inter- and intra-batch varia-
tion. Moreover, reduction of 3-[4,5-dimethylthiazole-2-yl]-2,5-
diphenyl tetrazolium bromide (MTT) was investigated in
control cultures and cultures treated with sodium lauryl
sulfate (SLS).
MATERIALS AND METHODS
Commercially available skin models
Reconstructed human epidermis. Three human epidermal constructs
were used: EpiDerm2 (MatTek Corporation, Ashland, MA, USA),
Episkin2 (Episkin SNC, Chaponost, France), and SkinEthic2
(Laboratoire SkinEthic, Nice, France). Two types of EpiDerm were
evaluated, i.e. hydrocortisone-free cultures (EPI-200-HCF) and per-
cutaneous absorption cultures (EPI-606A) (7, 19, 20). Episkin skin
models consisted cultures grown for 13 days (irritation model) or
20 days (penetration model) at the air-liquid interface (6, 18, 21).
SkinEthic cultures were grown for 18 days at the air-liquid inter-
face (8, 22, 23). Upon receipt of the cultures and according to the
specifications of the suppliers, Episkin and SkinEthic cultures were
stored overnight at 37‡C and 5% CO2, and EpiDerm cultures were
stored overnight at 4‡C. Three different batches of each model
were evaluated, except for 4 batches of EPI-200-HCF cultures and
4 batches of the SkinEthic model. All batches were manufactured
between January and July 1998.
In-house skin model. Normal human keratinocytes, cultured as
described earlier (24), were seeded on de-epidermized dermis (DED)
obtained from human cadaver skin (3). The cultures were first
grown under submerged conditions in a mixture of Dulbecco’s
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modification of Eagle’s medium and Ham’s F12 medium (3: 1)
(ICN Biomedicals Inc., Costa Mesa, CA, USA) supplemented with
5% HyClone serum (HyClone Laboratories Inc., Utah, USA),
100 IU/ml penicillin (ICN), 100 mg/ml streptomycin (ICN), 0.5 mM
hydrocortisone (Sigma Chemical Co., St. Louis, USA), 1.0 mM iso-
proterenol (Sigma) and 0.1 mM insulin (Sigma). After 1 day, the
cultures were grown submerged for an additional 2 days in a mix-
ture of DMEM/Ham’s F12 medium (3:1) supplemented with 1%
serum, 100 IU/ml penicillin, 100 mg/ml streptomycin, 0.5 mM hydro-
cortisone, 1.0 mM isoproterenol, 0.1 mM insulin, 10 mM carnitine
(Sigma), 10 mM serine (Sigma), 1 mM a-tocopherol (Sigma),
5.361028 M selenous acid (Johnson Matthey Materials Technol-
ogy, England), and enriched with a lipid supplement containing
25 mM palmitic acid, 15 mM linoleic acid, 7 mM arachidonic acid
and 24 mM bovine serum albumin (Sigma). Thereafter, the cultures
were lifted to the air-liquid interface and cultured for an additional
14 days in the same medium, except that serum was omitted, the
concentration of linoleic acid was increased to 30 mM and 50 mg/ml
ascorbic acid (Sigma) and 1 ng/ml epidermal growth factor (Sigma)
were added (11). Culture medium was renewed 3 times a week.
Test agent
SLS (Sigma) was dissolved in distilled water and used at a
concentration of 1.0%. After storage overnight upon receipt, fresh
medium was added and 26 ml of SLS was applied on the epidermal
surface for 3 or 16 h using a filter paper (0.5 cm2; Finn Chamber),
except for Episkin cultures in which 50 ml was applied on a 0.95 cm2
filter paper.
Morphology
Control and SLS-treated samples were fixed in 4% paraformaldehyde
and processed for embedding in paraffin. Vertical sections (5 mm)
were cut and stained with haematoxylin and eosin for light
microscopic examination.
Antibodies
Antibodies to K1 (LHK1) were kindly provided by Dr I. Leigh
(London), K6 antibodies (Ks6KA) were obtained from Progen
Biotechnik GmbH (Heidelberg, Germany), and K10 antibodies
(DEK10) were obtained from ICN Biomedicals Inc. (Costa Mesa,
CA, USA). Antibodies to skin-derived antileukoproteinase (SKALP)
were a kind gift of Dr J. Schalkwijk (Nijmegen), transglutaminase I
antibodies (BC1) were obtained from Biomedical Technologies Inc.
(Boston, MA, USA), involucrin antibodies (SY5) were kindly
provided by Dr F. Watt (London), loricrin antibodies (AF62) were
obtained from Berkeley Antibody Company BAbCO (Lakeside Dr
Richmond, CA, USA), and antibodies to small proline rich proteins
(SPRRs) were a gift of Dr D. Hohl (Lausanne).
Immunohistochemistry
Immunohistochemistry was performed on paraffin or cryostat
sections. Immunohistochemical analysis of keratin 1 (K1) and
transglutaminase was performed on 5 mm cryostat sections. For
detection of SKALP, involucrin, loricrin, SPRR2 and 3, a standard
method for antigen retrieval on paraffin sections was used. Prior
antigen retrieval of K6 and K10 the following modifications were
used; for K6, after deparaffinization, sections were immersed in
0.01 M sodium citrate buffer (pH 6.0) for 30 min at 100‡C followed
by slowly cooling to room temperature over a period of at least 3 h.
Incubation with the first antibody was performed overnight. For K10,
sections were immersed in preheated (to 100‡C) 0.01 M sodium citrate
(pH 6.0) for 30 min and were cooled to room temperature in 30 min,
followed by digestion in 0.04 mg/ml pepsin in 0.2 M HCl for 15 min
at room temperature. After incubation with primary antibodies, the
sections were stained with the avidin-biotin-peroxidase complex
method essentially as described by the suppliers (streptABCcom-
plex/HRP, DAKO, Glostrup, Denmark).
MTT assay
After overnight storage of the cultures according to the specifications
of the suppliers, distilled water or 1.0% SLS was applied for 3 or 16 h
at 37‡C and 5% CO2. Thereafter, the MTT assay essentially as
described by Mosmann (25) was performed. Briefly, after treatment
the cultures were rinsed with phosphate-buffered saline and
transferred to multiwell plates, each well containing freshly prepared
and filtered MTT solution at a concentration of 2 mg/ml culture
medium. After incubation for 2 h at 37‡C, the cultures were gently
blotted on tissue paper and transferred to a multiwell plate containing
3.3 ml isopropanol (acidified with 0.04 N HCl) per cm2 culture area,
and further incubated overnight at room temperature. A 200 ml
volume of the extractant solution was transferred to a 96-well
microtitre plate for measurement of the optical density at 550 nm and
a reference wavelength of 650 nm, using acidified isopropanol as a
blank.
RESULTS
Epidermal morphology
Investigation of vertical paraffin sections stained for histology
(Fig. 1) revealed a characteristic epidermal stratification in all
models. All cell layers were present, including stratum basale,
stratum spinosum, stratum granulosum and an anucleated
stratum corneum. Differences were observed in the number of
living cell layers. EpiDerm cultures (EPI-200-HCF) showed
an epithelium consisting of 9 – 12 living cell layers, whereas
the penetration models (EPI-606A) consisted of a lower
number of cell layers (5 – 7). In the latter, the keratinocytes
appeared more flattened in the upper cell layers compared
with EPI-200-HCF cultures. In particular in lower cell layers
in both EpiDerm models, intercellular spaces were clearly
visible. The basal cells showed a high cubical shape
progressively differentiating into 1 – 2 layers of flattened
granular cells containing keratohyalin granules. Concerning
tissue architecture, intra-batch variation was negligible and
only very small differences were observed between batches.
The number of living cell layers in Episkin cultures varied
between 8 – 10 in irritation models and 7 – 8 in penetration
models. Remarkably, penetration models consisted of a thick
and compact stratum corneum. All Episkin cultures showed 1
or 2 layers of cubically shaped basal cells and a relatively
abrupt transition to very flat cells in upper cell layers.
Granular cells containing keratohyalin granules were present,
but were flat, irregular and compact. Episkin cultures
demonstrated only low variation in tissue morphology
within batches, but some variation was observed between
batches with regard to the number of cell layers and the
degree of tissue organization.
SkinEthic cultures demonstrated a lower number of living
cell layers (5 – 7) compared with EpiDerm and Episkin
models. A basal layer of perpendicular-oriented, rounded
basal cells was shown which flatten out as the apical surface
of the tissue is approached. Intra-batch variation was low, but
considerable inter-batch was noticed showing variation in
thickness of the epidermis and sometimes pycnotic cells were
present in the stratum basale.
The number of cell layers in reconstructed epidermis on de-
Reconstructed skin models 83
Acta Derm Venereol 80
epidermized dermis (RE-DED) varied between 7 – 9 showing a
regular tissue arrangement, a gradual transition from
perpendicular-oriented basal cells to 1 or 2 layers of flattened
granular cells expressing keratohyalin granules. Intra- and
interbatch variations were low.
Expression and localization of differentiation markers
For examination of the differentiation process, immuno-
histochemical staining was performed using several specific
keratinocyte differentiation markers, including keratins and
precursors of the cornified envelope.
Keratins. As shown in Fig. 2, all skin equivalents expressed
K10, which was localized in suprabasal layers similar to
its expression in normal epidermis, although in Episkin
cultures K10 expression was found in higher epidermal
layers (spinous and granular layers) (Fig. 2C, D). Similar
observations were made for K1 (data not shown). K6, a
protein that is absent in normal human epidermis but is
often associated with wound repair, hyperproliferation and
abnormal differentiation (26 – 28), was differently expressed
in all models. In EpiDerm cultures (Fig. 2A, B) all supra-
basal layers were stained, but expression was more pro-
nounced in lower spinous and granular layers. Surprisingly,
K6 was only intermittently expressed in upper spinous
layers. Similar observations were made in SkinEthic cul-
tures (Fig. 2E). However, in some SkinEthic cultures K6
was homogeneously expressed in all suprabasal layers. In
contrast, in RE-DED cultures K6 expression occurred only
in lower suprabasal layers (Fig. 2F). A pronounced K6
staining was shown in all cell layers in Episkin cultures,
but some inter-batch variation was evident in staining pat-
tern of the stratum basale showing staining of either all or
only some basal cells (Fig. 2C, D). All cultures showed
some degree of staining in the stratum corneum. Whether
or not this is specific or aspecific staining is not yet
known.
Cornified envelope precursor proteins. The expression and
localization of cornified envelope precursor proteins;
SKALP, SPRR2 and SPRR3, involucrin, loricrin and trans-
glutaminase are shown in Table I. Expression of SKALP,
which is not detectable in normal human skin (29), was
demonstrated in all skin models. In EPI-200-HCF, SKALP
was strongly expressed in spinous and granular layers intra-
cellularly either below the upper cell membrane or through-
out the cytoplasm, whilst in EPI-606A expression was much
less pronounced and was found only intracellular below the
upper cell membrane in the upper stratum spinosum and
stratum granulosum. A comparable staining pattern was
observed in Episkin and SkinEthic cultures. Although
SKALP was more clearly expressed in EPI-200-HCF and
RE-DED, very low variation was demonstrated in distribu-
tion of SKALP in the epidermal layers both within and
between batches. SPRR2 was expressed in granular layers
in all skin models similar to normal human epidermis (30).
In EpiDerm samples, however, SPRR2 was intermittently
expressed in the stratum granulosum and only weak stain-
ing was observed in EPI-200-HCF cultures. Although
SPRR3 is absent in normal human epidermis, EPI-606A,
Episkin irritation models and RE-DED cultures, in EPI-
Fig. 1. Haematoxylin and eosin-stained paraffin sections of various skin models (a) SkinEthic; (b) EpiDerm EPI-200-HCF; (c) Episkin irrita-
tion model; (d) reconstructed epidermis on deepidermized dermis (RE-DED); (e) EpiDerm penetration model, EPI-606A; (f) Episkin penetra-
tion model. Each model demonstrated a completely stratified epidermis, the presence of numerous keratohyalin granules and the formation
of a coherent stratum corneum. Note the lower number of cell layers in EPI-606A and the thick and compact stratum corneum in Episkin
penetration models compared with the irritation models. Representative pictures are shown. All cultures were processed for staining after
overnight incubation according to the instructions by the manufacturer.
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200-HCF and Episkin penetration models a moderate inter-
mittent expression was demonstrated, and SkinEthic cul-
tures showed only a slight staining.
Loricrin was expressed in all skin models in the stratum
granulosum, similar as in native epidermis (31). Remarkably,
in Episkin penetration models expression was absent, except
for several cultures that showed some diffuse expression in
upper cell layers. Involucrin, normally only present
in granular layers (32), was expressed in all suprabasal
layers in EpiDerm, SkinEthic and Episkin cultures and in the
latter extended even into basal layers. Only RE-DED
cultures showed a correct expression of involucrin in the
stratum granulosum. Transglutaminase, an enzyme involved
in the crosslinking of cornified envelope precursors was
prematurely expressed in all skin models. In normal
epidermis it is confined to the stratum granulosum (33),
whereas in skin models staining was demonstrated in all
upper suprabasal layers. Small differences in expression of
transglutaminase were observed independent of the model or
batch tested.
MTT reduction
To evaluate MTT reduction as a measure of tissue viability
and to examine whether qualitative differences in skin
equivalents may induce differences in the outcome of the
MTT assay, the extent of keratinocyte maturation was varied
by exposure of RE-DED cultures to the air for different time
intervals.
In cryostat sections of RE-DED specimens harvested at day
3, 6, 14 and 5 weeks after air exposure and incubated for 2 h
in 2 mg/ml MTT solution, insoluble blue formazan crystals
were present in the lower cell layers whilst no staining was
noticed in upper cell layers (Fig. 3). Spectrophotometric
determination of the amount of reduced MTT demonstrated
no significant differences in optical density in cultures grown
at the air-liquid interface for 3, 6 or 14 days or for 5 weeks. In
addition, no differences in optical density values were
observed between RE-DED cultures grown in the absence
or presence of serum (data not shown). Variation in
supplementation of the culture medium, like omission of
ascorbic acid and a-tocopherol, omission of vitamins and
fatty acids during the last 3 days of culture, or variation of
fatty acid supplementation did not affect the amount of
reduced MTT (data not shown).
Examination of the extent of MTT reduction in different
skin models demonstrated high similarities between vehicle-
treated conditions, but marked differences were observed
when 1.0% SLS was applied topically for 3 or 16 h;
conditions at which important changes in histologic
appearance of the epidermis have been observed (Fig. 4)
RE-DED cultures showed the highest resistance to damaging
effects of SLS, resembling the effects of SLS treatment of
freshly excised human skin specimens. Although variation in
optical density between the industrial skin models was
relatively low upon application of 1.0% SLS for 16 h,
differences were observed after 3 h application. Most
pronounced effects were noticed in SkinEthic cultures,
whilst EpiDerm cultures and Episkin cultures showed
intermediate optical density. In general, inter- and intra-
batch variations were low, implicating high reproducibility of
Fig. 2. Immunohistochemical staining of K10 and K6 in vertical
paraffin sections of reconstructed skin models (A) EpiDerm, EPI-
200-HCF; (B) Epiderm penetration model, EPI-606A; (C) Episkin
irritation model; (D) Episkin penetration model; (E) SkinEthic; (F)
RE-DED. Note the expression of K6 in all models and the correct
expression of K10 in all suprabasal layers, except for Episkin cul-
tures showing staining only in higher suprabasal layers.
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the MTT assay and low dependence on tissue architecture of
the skin equivalents.
DISCUSSION
Our study showed that all reconstructed human skin
equivalents evaluated in this study closely resembled native
human epidermis. A fully differentiated epidermis was
demonstrated with all epidermal strata and a regular tissue
arrangement consisting of a physiological number of living
cell layers. Both inter- and intra-batch differences were
evident with regard to morphological and biochemical
parameters.
K1/K10, which are localized in all suprabasal layers in
native human skin (34) and thus serve as early markers of the
epidermal differentiation process, were shown to be correctly
expressed in all models, except for Episkin cultures in which a
later onset of expression was demonstrated implicating a
delayed epidermal differentiation in these cultures. The
proliferation/differentiation balance, however, is disturbed in
all skin models as was demonstrated by the presence K6 and
SKALP, which are absent in normal epidermis, but which
have been demonstrated in hyperproliferative epidermis and
during wound healing (27 – 29, 35). Localization of K6
expression varied between models, which may indicate
differences in tissue homeostasis between models. Our results
clearly showed that a low SKALP expression did not parallel
a decreased K6 staining. In support of these findings, it has
been reported that regulation of keratinocyte proliferation
can be separated from the regulation of K6 expression (10,
26). In this view, cultures may reveal a normal proliferation
rate but nevertheless express K6 and SKALP.
Concerning the other markers of terminal differentiation,
some differences in expression were found in the skin models.
In particular the presence of SPRR3 in EpiDerm, Episkin
penetration and SkinEthic cultures, and the premature
expression of transglutaminase and involucrin in all models,
support the observations of an imbalance in keratinocyte
homeostasis and possible alterations in the synthesis of
cornified envelope precursors. The ubiquitous extension of
differentiation-specific protein markers in lower epidermal
layers has previously been shown to occur in epidermal
hyperplasia and during tissue repair (26, 28, 36, 41). In
general, differences in the expression of these markers
between skin models and the inter- and intra-batch variation
may be primarily a result of culture conditions (10, 12,
36 – 38), implicating that an improvement in culture
conditions may be sufficient to achieve a normalized protein
distribution.
Besides a balanced proliferation/differentiation status of the
epidermis, the development of a proper stratum corneum is
equally important as it plays a key role in skin barrier
function and therefore in the response to toxic substances. To
determine cell survival after a toxic assault, the colorimetric
MTT reduction assay that measures the activity of various
dehydrogenase enzymes in active mitochondria, has often
been used in both monolayer cultures and epidermal
equivalents (15, 18, 21, 25, 39, 40). Our data showed that
MTT is mainly reduced in the lower cell layers and that
optical density in RE-DED cultures was not significantly
influenced by variation in epidermal thickness, suggesting that
Table I. Expression of proteins involved in cornified envelope formation
Model SKALP SPRR2 SPRR3 Loricrin Involucrin Transglutaminase
EpiDerm, EPI-200-HCF SS, SG [strong] SG [intermittent] SG [intermittent] SG SPB upper SPB
EpiDerm, EPI-606A Upper SS, SG SG [intermittent] absent SG SPB upper SPB
Episkin, Irritation model Upper SS, SG SG absent SG SPB upper SPB
Episkin, Penetration model Upper SS, SG SG SG [intermittent] absent SPB upper SPB
SkinEthic Upper SS, SG SG SG [weak] SG SPB upper SPB
RE-DED SS, SG [strong] SG absent SG SG upper SPB
SB, stratum basale; SS, stratum spinosum; SG, stratum granulosum; SPB, suprabasal layers.
Fig. 3. Nuclear fast red staining of RE-DED cultured for 3 – 5 weeks at the air-liquid. Tissue specimens were frozen in liquid nitrogen and
embedded in TissueTek after MTT reduction for 2 h at 37‡C. Data are presented as the mean optical density (OD) ¡SEM of triplicate
measurements in two independent experiments. Values are given per 0.8 cm2 culture area per 2.6 ml extraction solution.
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terminally differentiated keratinocytes may not be involved
in MTT reduction although these keratinocytes are still
metabolically active. In addition, determination of MTT
reduction did not demonstrate significant differences between
the various skin equivalents in the vehicle-treated cultures.
However, the optical density measured after application of
vehicle for 16 h tended to be lower compared with 3 h
treatment with the vehicle, indicating a slightly impaired
barrier function. SLS treatment resulted in optical densities
close to zero in the industrial skin models, i.e. no MTT
reduction occurred due to cell death. Differences in suscept-
ibility to SLS between the industrial skin models were only
evident at early time points after topical application of the
irritant and indicated that EpiDerm cultures were most
resistant to SLS-induced toxicity. In contrast, in excised skin
and in RE-DED cultures only a slight decrease in mitochon-
drial metabolic activity was noticed, clearly indicating that
measurement of MTT reduction indirectly reflects the quality
of the stratum corneum barrier and that the MTT assay may
be used to assess both the ability of test compounds to
penetrate the stratum corneum as well as their ability to affect
cellular viability.
In conclusion, although substantial progress has been
made in improvement of the quality of skin equivalents
with respect to tissue architecture and function, their
phenotype still represents that of a hyperproliferative tissue
or of a recently healed wound. Furthermore, the quality of
commercially available skin equivalents depends not only on
culture conditions but also on package and shipping
procedures. Both aspects should be considered when aiming
for further progress of the quality of in vitro reconstructed
human skin.
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